Current pharmaceutical biotechnology, cilt.21, ss.681-701, 2020 (SCI-Expanded, Scopus)
Background: The role of Fe+2, Cu+2 and Zn+2 in facilitating aggregation of Amyloid beta (A beta) and consequently, the progression of Alzheimer's disease (AD) is well established.